Bill would up penalty on EpiPen makers for flouting Colorado price cap
A bill in the Colorado legislature would allow stiffer penalties for EpiPen and insulin manufacturers who refuse to sell their products under the state’s price caps, which one generic drugmaker is challenging in court. Over the last three years, Colorado set limits on out-of-pocket costs for insulin and epinephrine auto-injectors. So far, insulin makers largely … Read more
